{
    "code": "02021128",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021128",
    "time": "2016-03-11 03:06:13",
    "許可證字號": "衛署藥輸字第021128號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/06\/08",
    "發證日期": "85\/01\/03",
    "許可證種類": "製　劑",
    "舊證字號": "02020939",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202112800",
    "中文品名": "\/明克注射劑",
    "英文品名": "PRIMACOR I.V. INJECTION",
    "適應症": "充血性心衰竭的短期療法",
    "劑型": "270注射劑",
    "包裝": "10毫升安瓿 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "MILRINONE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": {
        "製造廠名稱": "F150141100  SANOFI WINTHROP INDUSTRIE",
        "製造廠廠址": "6, BOULEVARD DE L'EUROPE 21800 QUETIGNY FRANCE",
        "製造廠公司地址": "22, AVENUE GALILEE 92350 LE PLESSIS ROBINSON FRANCE",
        "製造廠國別": "FRANCE",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F150211100  SANOFI-AVENTIS FRANCE",
            "製造廠廠址": "1-13, BOULEVARD ROMAIN ROLLAND 75014 PARIS FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2404300700",
            "成分名稱": "MILRINONE",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PRIMACOR_LPI_E_CCDS v07_TFDA app 2016.02.16-105-02-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=007&Type=9"
        },
        {
            "title": "PRIMACOR_LPI_C_CCDS v07_TFDA app 2016.02.16 clean-105-02-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=006&Type=9"
        },
        {
            "title": "PRIMACOR_leaflet_C_CCDS v6_approved+Excipients-102-12-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=005&Type=9"
        },
        {
            "title": "PRIMACOR_leaflet_E_CCDS v6___20120704.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=004&Type=9"
        },
        {
            "title": "PRIMACOR_leaflet_C_CCDS v6___20120704.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=003&Type=9"
        },
        {
            "title": "020211280002.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=002&Type=9"
        },
        {
            "title": "020211280001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=001&Type=9"
        },
        {
            "title": "020211280006.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=006&Type=8"
        },
        {
            "title": "020211280005.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=005&Type=8"
        },
        {
            "title": "020211280004.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=004&Type=8"
        },
        {
            "title": "020211280003.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=003&Type=8"
        },
        {
            "title": "020211280002.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=002&Type=8"
        },
        {
            "title": "020211280001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021128&Seq=001&Type=8"
        }
    ]
}